Pliant Therapeutics, Inc. (PLRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -19.23M | -17.79M | -21.08M | -40.6M | -48.86M | -47.66M | -32.27M | -45.3M | -30.27M | -25.1M | -36.22M | -24.76M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | -9983.47% |
| Operating CF Growth % | 60.65% | 62.68% | 34.68% | 10.36% | -61.42% | -89.87% | 10.91% | -82.95% | 0.02% | 19.65% | -95.83% | -1.49% |
| Net Income | -20.04M | -23.58M | -26.3M | -43.3M | -56.17M | -49.73M | -57.76M | -55.85M | -46.95M | -41.11M | -41.49M | -41.19M |
| Depreciation & Amortization | 264K | 365K | 436K | 447K | 448K | 458K | 532K | 622K | 513K | 464K | 448K | 477K |
| Stock-Based Compensation | 0 | 4.53M | 0 | 6.38M | 8.91M | 8.42M | 8.9M | 10.64M | 9.67M | 9.15M | 10.36M | 13.05M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.7M | -3.93M |
| Other Non-Cash Items | 5.41M | 2.94M | 7.53M | 2.79M | 2.17M | 1.38M | 1.81M | 1M | 1.77M | 5.78M | 597K | 627K |
| Working Capital Changes | -4.87M | -2.04M | -2.75M | -6.92M | -4.23M | -8.18M | 14.25M | -1.71M | 4.73M | 609K | -2.44M | 6.21M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.58M | 1.72M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -118K | -3K | -897K | -4.24M | -338K | -930K | 3.73M | -3.63M | 2.26M | 1.17M | 1.06M | 882K |
| Cash from Investing | -4.1M | 1.77M | 27.92M | 35.49M | 69.11M | 39.13M | 30.96M | 10.7M | 59.55M | 31.92M | 38.25M | -22.98M |
| Capital Expenditures | 0 | 0 | 156K | -112K | -262K | -209K | -896K | -1.25M | -1.49M | -61K | -94K | -603K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 243.15% |
| Acquisitions | 102K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.35M | 22.38M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38.35M | -22.38M |
| Cash from Financing | 74K | -32.27M | 72K | 0 | 498K | 102K | 543K | 684K | 21.79M | 219K | 699K | 161K |
| Debt Issued (Net) | 0 | -32.27M | 0 | 0 | 0 | 1K | 0 | 0 | 19.91M | 0 | 0 | 0 |
| Equity Issued (Net) | 74K | 0 | 72K | 0 | 498K | 101K | 543K | 2.56M | 1.88M | -4.78M | 774K | 4M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.88M | 0 | 5M | -75K | -3.83M |
| Net Change in Cash | -23.25M | -48.29M | 6.91M | -5.12M | 20.75M | -8.43M | -770K | -33.91M | 51.06M | 5.55M | 2.73M | -47.58M |
| Free Cash Flow | -19.23M | -17.79M | -21.08M | -40.72M | -49.13M | -47.87M | -33.17M | -46.55M | -31.76M | -25.16M | -36.32M | -25.36M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | -10226.61% |
| FCF Growth % | 60.86% | 62.84% | 36.44% | 12.53% | -54.66% | -90.24% | 8.67% | -83.53% | -4.35% | 19.88% | -89.22% | -2.89% |
| FCF per Share | -0.31 | -0.29 | -0.34 | -0.66 | -0.80 | -0.79 | -0.55 | -0.77 | -0.53 | -0.42 | -0.61 | -0.43 |
| FCF Conversion (FCF/Net Income) | 0.96x | 0.75x | 0.80x | 0.94x | 0.87x | 0.96x | 0.56x | 0.81x | 0.64x | 0.61x | 0.87x | 0.60x |
| Interest Paid | 0 | 0 | 735K | 734K | 723K | 770K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |